Company / SG&A Expense
CLOVER HEALTH INVESTMENTS, CORP. /DE SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$214.3M
FY2025
5-year range
$176.5M / $214.3M
FY2021-FY2025
Trend
+21.4%
vs FY2024
Sector context
#104 of 158
Health Care
What the data says
At $214M, CLOVER HEALTH INVESTMENTS, CORP. /DE's sg&a expense ranks #55 of 158 in the Health Care sector. SG&A Expense returned to growth in FY2025 after 2 years of decline, reaching $214M.
Based on SEC 10-K filings.
$214M in FY2025 with a 5-year CAGR of +12.1%.
Increased from $183M to $214M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#55 of 158 in Health CareTop 34% of 158This company $214.3M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 21.4% year-over-year.
- Ranks #104 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $214.3M | +21.4% |
| FY2024 | $176.5M | -3.6% |
| FY2023 | $183.1M | -10.1% |
| FY2022 | $203.7M | +9.9% |
| FY2021 | $185.3M | +53.3% |
| FY2020 | $120.8M | +26.3% |
| FY2019 | $95.7M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026